(Q33340371)

English

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

9

object named as

M A Dimopoulos

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

D Pectasides

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

G Aravantinos

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Kalofonos

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Kiamouris

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Bafaloukos

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Xiros

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Nicolaides

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Visvikis

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1417-1422

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Gallium nitrate in advanced bladdercarcinoma: Southwest oncology group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1012599307090

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1012599307090

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340371&oldid=2042206018"